Skip to main content

Table 1 Clinical features

From: Weekly chemotherapy as first line treatment in frail head and neck cancer patients in the immunotherapy era

Parameter

EXTREME

PCC schedule

Total

p value

N

103

21

124

 

Age, mean (SD)

68.2 (11.1)

69.3 (10.8)

68.4 (11.0)

0.6798

  < 65

33 (32.0)

6 (28.6)

39 (31.5)

0.947

  65–75

41 (39.8)

9 (42.9)

50 (40.3)

   > 75

29 (28.2)

6 (28.6)

35 (28.2)

Male

72 (69.9)

17 (81.0)

89 (71.8)

0.427

Alcohol

29 (28.2)

4 (19.0)

33 (26.6)

0.588

Smoke during treatment

22 (21.4)

4 (19.0)

26 (21.0)

1.000

Baseline PS

 0

39 (37.9)

0 (0)

39 (31.5)

< 0.0001

 1

64 (52.4)

0 (0)

64 (52.4)

 2

0

21 (100)

21(26.04)

Toxicity all G

70 (68.0)

11 (53.0)

70 (56.5)

< 0.0001